1 / 14

Protein misfolding diseases

Protein misfolding diseases. 12-1. Diseases caused by mutations in chaperones - α-crystallin, MKKS/BBS6 chaperonin Neurodegenerative diseases prions, Huntington’s disease. Neurodegenerative disorders: prions. 12-2.

kendall
Télécharger la présentation

Protein misfolding diseases

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Protein misfolding diseases 12-1 • Diseases caused by mutations in chaperones • - α-crystallin, MKKS/BBS6 chaperonin • Neurodegenerative diseases • prions, Huntington’s disease

  2. Neurodegenerative disorders: prions 12-2 • pathogenesis of many neurodegenerative disorders is due to abnormal protein conformation • common theme in diseases is conversion of normal cellular and/or circulating protein into an insoluble, aggregated, beta-sheet rich form which is deposited in the brain as an amyloid • deposits are toxic and produce neuronal dysfunction and death • prion-related diseases occur when conversion of a normal prion protein, PrP, into an infectious and pathogenic form, PrPSc (Prion Protein Scrapie). Prion diseases: • Creutzfeld Jacob disease, Kuru, Gerstmann-Straussler-Scheinker disease, Fatal familial insomnia, Scrapie (sheep), Bovine spongiform encephalopathy (BSE or ‘mad cow’), chronic wasting disease (mule deer, elk), feline spongiform encephalopathy • the conversion of PrP into PrPSc is a conformational one; the PrPSc form is moreresistant to proteases and is detergent-insoluble • PrPSc forms amyloid fibrils in the brain; injection of this material into the brains of normal mice leads to disease • the normal function of PrP is unknown; transgenic mice lacking this protein grow normally • Other proteins unrelated in sequence to PrP have similar properties: • e.g., yeast Sup35, Ure2p

  3. Prion transmission characteristics 12-3 harbours hamster PrPSc harbours murine PrPSc contains hamster PrP (lacks mouse PrP) contains hamster PrP (lacks mouse PrP) Note: - testing for infectivity with PrPSc is done by injecting brain material from an infected animal into the brain of another animal - transgenic mice devoid of mouse PrP cannot be infected by mouse PrPSc

  4. Class Presentations • TRiC stands for TCP-1 Ring Complex and is the same eukaryotic cytosolic chaperonin as CCT (Chaperonin containing TCP-1). • CCT was first thought to assist the folding of only actins and tubulins, but recently, it has been found to bind ~10% of all cell proteins and is known to assist the folding of numerous other proteins, including a viral capsid protein, myosin, luciferase and VHL. Feldman et al. (1999) Formation of the VHL-Elongin BC tumor suppressor complex is mediated by the chaperonin TRiC. Mol. Cell4, 1051-1061. • there exists a cellular mechanism by which misfolded/aggregated proteins are sequestered in the cell • such sequestration occurs near the centrosome in an organelle-like structure commonly termed ‘aggresome’ Johnston et al. (1998) Aggresomes: a cellular response to misfolded proteins. J. Cell Biol.143, 1883-98. 12-4

  5. Neurodegenerative disorders: Huntington’s disease 12-5 • Huntington’s disease (HD) is a very common syndrome that affects numerous people • It is caused by the expansion of CAG trinucleotide repeats (encoding polyglutamine) within a large protein (350 kDa) termed huntingtin • the function of huntingtin is unclear; evidence points to trafficking (vesicular) • normal and disease forms • unaffected individuals carry between 6 and 39 repeats in exon 1 of huntingtin • HD patients typically have between 36-180 repeats in exon 1 of huntingtin • mutant forms of huntingtin with expanded repeats form nuclear and cytoplasmic aggregates in human brain tissue

  6. Huntington’s disease: in vitro model system 12-6 • can express protein fusion with different numbers of CAG repeats and study • Muchowski et al. (2000) PNAS 97, 7841. produced GST-HD proteins (HD20Q and HD53Q) then cleaved off HD from tag using protease that cleaves between GST and HD; aggregation was then followed in the presence or absence of chaperones • found that combination of Hsp40 and DnaK were most effective at preventing aggregation time course of aggregation detected by ‘filter trap’ assay after 8 hours; aggregation assayed as in (A) time course of aggregation

  7. Huntington’s disease: in vitro model system 12-7 control Hdj-1 • GST-HD proteins were induced to aggregate by cleavage (as before) in the presence or absence of chaperones • fibrils/aggregate formation was observed by electron microscopy Suppression of HD exon 1 fibril formation by Hsp40 and Hsp70 in vitro. GST-HD fusion protein (3 µM) was incubated with PreScission protease for 5 h as in previous slide: in the absence (A) or presence (B-F) of chaperones (6 µM) (B) DnaK (C) DnaJ (D) Hdj-1 (E) Hsc70/ATP (F) Hsc70/Hdj-1/ATP (Hsc70/Hdj-1 = 2:1). Samples then were analyzed by EM. (Bar = 100 nm.) Hsp70/ATP DnaK DnaJ Hsc70/Hdj-1

  8. Huntington’s disease: in vivo yeastmodel system 12-8 • Huntingtin constructs with Exon 1 and containing 20, 39 or 53 CAG repeats as well as a c-myc tag (which is recognized by antibody and can be immunoprecipitated) were expressed in S. cerevisiae • (A) *=SDS-insoluble aggregates that do not penetrate the gel • (A) **=degradation product of full-length protein • (B) filter-trap assay; T=total, S=soluble, P=pellet after centrifugation • (D) immunoprecipitation of different proteins with anti Ssa (cytosolic) and Ssb (ribosome-bound) Hsp70 protein homologues from yeast, as well as anti-Ydj1 (Hsp40 homologue) • High-level expression of Hsp70/40 in yeast with HD53Q made the aggregates SDS-soluble! (not shown)

  9. Huntington’s disease: Drosophila model system 12-9 • expressed HA-tagged 127 CAG repeat-protein (127Q) in the eye, causing abnormalities/polyQ deposits • GMR has 5 tandem copies of a response element derived from the rhodopsin 1 gene promoter) • GAL4 is a transcription factor • UAS, ‘Upstream Activating Sequence’ required for GAL4-dependent gene expression • flies carrying GMR-GAL + UAS127Q were crossed with EP-element insertion strains (7000) • screened for suppression or enhancement of toxicity • found: dhdJ1, an Hsp40 homologue; dtpr2 is a TPR-containing protein with J domain • still see aggregates (as with the in vitro studies) Esfarjani and Benzer (2000) Science287, 1837.

  10. TRANSGENIC STRAIN CARRYING GMR PROMOTER-GAL4 CONSTRUCT (HIGH-LEVEL EXPRESSION IN EYE) GMR GMR GMR GMR GMR GAL4 CONTRUCT CROSSED INTO THE ABOVE STRAIN (UAS ACTIVATED BY GAL4 TO INDUCE HIGH-LEVEL EXPRESSION OF 127Q) UAS 127Q

  11. α-crystallin and disease 12-10 • α-crystallin belongs to the class of molecular chaperones collectively termed small heat-shock proteins • functions include (but is not limited to) maintaining microfilament stability (e.g., intermediate filaments and perhaps actin and tubulin) • present in all tissue types and ubiquitous in the three domains mutations in α-crystallin genes A and B cause some major ailments: • cataracts - function is as a structural protein as well as a molecular chaperone; it makes up nearly 1/3 of the eye lens protein, while β- and γ-crystallins make up close to the other 2/3 • desmin-related myopathy - desmin is an intermediate filament; mutation in the chaperone result in the accumulation of intracellular aggregates of desmin (co-aggregation with α-crystallin occurs) • Alexander’s disease - the neurodegenerative Alexander's disease is characterized by GFAP co-aggregateswith α-crystallin; GFAP is closely related to desmin

  12. α-crystallin-GFAP experiment 12-11 • R120G α-crystallin mutant is found in some patients • the chaperone activity of the R120G mutant (located in the highly conserved α-crystallin domain) is not completely lost compared to the wild-type chaperone intact (as judged by prevention-of-aggregation experiments) • reason why the mutant chaperone associates more strongly with GFAP (and desmin) is unclear • specificity of binding causing the problem? GFAP + wt α -crystallin GFAP + R120G α -crystallin Association of α-crystallin (wild-type and mutant) with GFAP at 37ºC Perng et al. (1999) J. Biol. Chem.274, 33235.

  13. MKKS/BBS6 mutations cause disease 12-12 • MKKS/BBS6 is one of 12 genes that cause Bardet-Biedl Syndrome (i.e., a polygenic disorder) • mapping of BBS genes relied on screening inbred populations (e.g., Bedoin arabs, Old Order Amish, Newfoundland) • BBS phenotypes: obesity, kidney and liver problems, retinal degeneration, cardiomyopathy, diabetes, mental retardation, anosmia, hearing impairment, polydactyly, etc. • MKKS/BBS6 is related to the chaperonin CCT • two other chaperonin-like genes were found: BBS10, BBS12

  14. MKKS/BBS6 and other BBS alleles 12-13 • the chaperonin is related to the eukaryotic cytosolic chaperonin CCT • it is found only in vertebrates and ‘more evolved’ organisms • it is highly divergent although it is clearly a Group II chaperonin E, equatorial domain A, apical domain I, intermediate domain P, protrusion E I A P A I E • BBS4 is involved in microtubule anchoring; it contains multiple TPR motifs: 34 amino acid repeats of helix-loop-helix - TPRs are protein-protein interaction domains • BBS proteins are required for proper cilia function; BBS is therefore a ciliopathy • improper function of ciliary genes results in numerous ailments, including retinal degeneration, polycystic kidneys, skeletal anomalies, etc.

More Related